Search

Home > OIS Podcast > Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials
Podcast: OIS Podcast
Episode:

Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials
Category: Business
Duration: 00:17:44
Publish Date: 2015-01-05 23:00:00
Description: Eleven Biotherapeutics capitalized on exciting technology and promising clinical results for its lead Dry Eye product to stage a successful IPO in 2014. Abbie C. Celniker, PhD, President and CEO, talks frankly about her leadership style, dealing with public investors, and how she’s man-aging high expectations for lead product EBI-005.
Total Play: 0